Flashcards
Feb 4 Tues
Cards in this deck (47)
- 1PlasmalogenFA at position 1 is an unsaturated alkyl group attached to glycerol by ether (rather than an ester) linkage
Phosphatidalethanolamine
phosphatidalcholine - 2Phosphatidalethanolamine phosphatidalcholineis abundant in nerve tissue
in cardiac muscle - 3Platelet-Activating Factorfirst signaling pthway in response to inflammtory signal
Promotes oxidative burst of leukocytes (white blood cells) associated with host defense - 4Cardiolipin Biosynthesis 2 stepsActivation of phosphatidic acid by CTP to from CDP-DAG
Condensation with glycerol 3-phosphate to form PG-P - 5Cardiolipin Biosynthesis next 2 stepsHydrolysis of phosphoester bond to form phosphatidylglycerol (PG)
Condensation with activated DAG (i.e., CDP-DAG) to form cardiolipin (CL) - 6Cardiolipinimporant for attaching compelxes in ETC
Facilitates maintenance of proton motive force and anchors cyt c to inner mitochondrial membrane - 7Phosphatidylinositol (PI) synthesizied frominositol and CDP-diacylglycerol,
- 8PIa reservoir of arachidonic acid, precursor for
Phosphorylation of PI produces PIP2 - 9PIP2 gives way toDAG and IP3
- 10Arachidonic acidbecomes porataglandin thru action of cyclooxygenase enzymes (COX1 and COX2)
becomes leukotrienes thru action of lipoxgenase (LOX) - 11Prostaglandin synthesis is inhibited byInhibition of phospholipase A2 (cortisol; steroidal anti-inflammatory).
Aspirin (NSAID) acetylates active site and inhibits both COX1 and COX2.
Celecoxib (NSAID) selectively inhibits COX2. - 12prostaglandin is imporantin inflammaotry response to inbiting it would inhibit infammation response
- 13Aspirin Inhibits cyclooxygenase 1 (COX1) byacetylating Ser530 that blocks active site Tyr385 to block arachidonic acid binding (and blocks thrombosis).
Inhibits cyclooxygenase 2 (COX2) by a similar mechanism. - 14OH group at carbon 1 of sphingosine is esterified tophosphorylcholine
sphingomyelin - 15Degradation of SphingomyelinSphingomyelinase removes phosphorylcholine.
Accumulation of sphingomyelin in lysosomes (lysosomal storage disease). - 16Niemann-Pick DiseaseAccumulation of sphingomyelin in lysosomes (lysosomal storage disease) becus sphoinomyelinase defincency
- 17Niemann-Pick Disease affectNo treatments for type A (severe disorder): death in early childhood
Results in loss of myelin in CNS (main pathology) - 18surfactantsProduced by type II alveolar epithelial cells in the lungs
---Lipids, protein and carbohydrates
Surfactant lipids form a monolayer - 19Surfactants in infantsPreterm infants with immature lungs are surfactant deficient
Develop respiratory distress syndrome - 20Composition of SurfactantDipalmytoyl phosphatidylcholine (DPPC) or dipalmitoyl lecithin is the highest among lipids
- 21Surfactant types ProteinsHydrophilic glycoproteins
SP-A (~35 kDa)
SP-D (~43 kDa)
Hydrophobic proteins
SP-B (~8.7 kDa)
SP-C (~4.2 kDa) - 22Surfactant Protein C (SP-C)Facilitates monolayer spreading
and recruitment of lipids to
the surface films - 23Surfactant Protein B (SP-B)SP-B deficiency due to gene mutations
are associated with respiratory distress
in neonatal period - 24Surfactant Proteins A and D structureOctadecameric SP-A and
dodecameric SP-D
SP-A has six trimers
SP-D has four trimers
SP-A and D bind lipids - 25SP-A participates inorganizing alveolar surfactant phospholipids
- 26SP-A and Dhave a major role in regulating immune and inflammatory response
- 27SP-Bis required for assembly and its extracellular development
----Deficiency of SP-B is incompatible with life - 28SP-B mutations associate withfatal respiratory distress syndrome in neonates
- 29Life Cycle of Pulmonary SurfactantBiosynthesis and processing of phospholipids and proteins
ER and Golgi bodies
Transported to and stored (except SP-A) in
Lamellar bodies (LB)
-LB have a limiting lamellar bilayer membrane
-Limiting membrane fuses with plasma membrane - 30life cycle part 2Contents released
-PL associates with proteins and assemble onto SP-A to form tubular myelin (TM)
-TM formation is calcium dependent
-At high pressure and low lung volume desorption and endocytosis of components occurs - 31Lung maturity of the fetus is determined bythe ratio of DPPC to sphingomyelin (L/S ratio)
L/S ratio of >2.0 indicates lung maturity
A major shift occurs in the synthesis from sphingomyelin to DPPC at about 32 weeks of gestation - 32Lung Maturity TestsL/S ratio
-Lecithin (PC) and sphingomyelin from amniotic fluid by TLC
-Fluorescence polarization of amniotic lipids
-Foam stability index
-Lamellar body count - 33Vascular Resistanceinput pressure - output pressure
blood flow (same as systemic circulation) - 34Pulmonary Vascular Resistance (PVR) is1/10 of SVR
- 35Comparing to the systemic circulation, the pulmonary circulation:Circulating pressures are remarkably low.
Pulmonary vascular resistance is remarkably low.
Blood vessel walls are thin at all levels.
Containing far less smooth muscles. - 36Majors factors affect pulmonary vascular resistance (PVR)-Changing cardiac output
-Changing lung volume
-Hydrostatic pressure
of the blood vessels
-Reducing the alveolar PO2 - 37Changing cardiac outputDuring exercise cardiac output increases (e.g. 5-fold), but with little change in mean pulmonary artery pressure.
- 38In order to keep pressure unchanged, the PVR mustdecrease
by
Recruitment: Opening of previously collapsed capillaries
Distension: Increase in diameter of open capillaries. - 39Effect of lung volume on PVRPVR is lowest near FRC and increases at both high and low lung volume because of the combined effects on the alveolar and extra-alveolar vessels.
- 40Zone 2Effective driving pressure is
Pa – PA. - 41Zone 3Effective driving pressure is
Pa – Pv. - 42zone 1little blood flow
- 43Effect of decreased alveolar PO2 on pulmonary blood flow.Decrease in alveolar PO2 leads to an increase in pulmonary vascular resistance (PVR), and as a result disease in pulmonary blood flow
- 44Hypoxic pulmonary vasoconstriction (HPV)Alveolar hypoxia constricts small pulmonary arteries and increases PVR.
HPV leads to pulmonary hypertension.
Directs blood flow away from poorly ventilated areas of the diseases lung, e.g. pulmonary edema.
General hypoxemia (high altitude or hypoventilation) can cause extensive pulmonary artery vasoconstriction. - 45V/Q mismatchis a condition in which one or more areas of the lung receive oxygen but less/no blood flow, or they receive blood flow but less/no oxygen due to some diseases and disorders.
- 46V/Q mismatch causeshypoxemia.
- 47—
Information
- Description
- Flashcards on Feb 4 Tues, created by Shylla T on 04/02/2020.
- Created by
- Shylla T
- Views
- 4
- Rating